Everolimus (Everolimus) — NDC 49884-127 by Par Health USA, LLC
Everolimus (Everolimus) — NDC 49884-127 by Par Health USA, LLC is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Everolimus; Generic name: Everolimus; Product NDC: 49884-127.
| Brand name | Everolimus |
|---|---|
| Generic name | Everolimus |
| Product NDC | 49884-127 |
| Labeler | Par Health USA, LLC |
| Dosage form | TABLET |
| Route | ORAL |
| Active ingredients | EVEROLIMUS 7.5 mg/1 |
| Pharmacologic class | Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressa |
| Marketing category | ANDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →